PlainRecalls
FDA Drug Low Class III Ongoing

Ramipril Capsules, USP, 1.25 mg, 30-count bottle, Rx only, Manufactured by: Arrow Pharm (Malta) Ltd., Birzebbugia, BBG3000, Malta; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 16252-570-30.

Reported: November 9, 2016 Initiated: August 30, 2016 #D-0118-2017

Product Description

Ramipril Capsules, USP, 1.25 mg, 30-count bottle, Rx only, Manufactured by: Arrow Pharm (Malta) Ltd., Birzebbugia, BBG3000, Malta; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 16252-570-30.

Reason for Recall

Labeling: Incorrect or Missing Lot And/or Exp Date: Bottles labeled with the incorrect expiration date of 03/18 rather than 09/17.

Details

Units Affected
15,984 bottles
Distribution
Nationwide and Puerto Rico
Location
Davie, FL

Frequently Asked Questions

What product was recalled?
Ramipril Capsules, USP, 1.25 mg, 30-count bottle, Rx only, Manufactured by: Arrow Pharm (Malta) Ltd., Birzebbugia, BBG3000, Malta; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 16252-570-30.. Recalled by Actavis Laboratories, FL, Inc.. Units affected: 15,984 bottles.
Why was this product recalled?
Labeling: Incorrect or Missing Lot And/or Exp Date: Bottles labeled with the incorrect expiration date of 03/18 rather than 09/17.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 9, 2016. Severity: Low. Recall number: D-0118-2017.